TETRAGRIP II - Usability Trial of an FES Orthosis for People With Tetraplegia.

NCT04964635 | Completed DMC

• 1 other identifier: RED 10356
• Study Type: interventional
• Target: 4
• Locations: 1 country
• Sites: 1

Brief Summary

Functional Electrical Stimulation is an established technique in which small electrical impulses are used to cause a contraction in muscles and thereby enable movement, in people with neurological or musculoskeletal problems who are unable to undertake those movements themselves. People with spinal cord injuries of the neck at C5, C6 and C7 account for 35% of all spinal cord injuries. Despite this, there is only one commercial FES (Functional Electrical Stimulation) based orthosis currently available. Even that has limitations in that it as it has a single size rigid exoskeleton it does not fit all people who could benefit and also due to its rigidity it does not allow people with lower injuries to utilise any remaining tenodesis grip. As a result, it is not widely used within the spinal injured communities. Therefore what is required is a more flexible system that can benefit a larger number of people whilst still being affordable within the constraints of the NHS. A previous INSPIRE funded project, TETRAGRIP I demonstrated that a surface FES system controlled by an inertial sensor, measuring movement of the opposite shoulder, could meet this specification and was successfully tried on two people with tetraplegia. What is now required is a more detailed study in which the principle components of that system are incorporated into a practical device suitable for use at home without clinical supervision. It is therefore proposed to develop and build such a system and to conduct extended home based trials in three people with tetraplegia.

Conditions

Spinal Cord Injuries; Tetraplegia

Outcome Measures

Primary Outcomes (3)

• Grasp Release Test (GRT)

  Test to be completed both with and without the device - exercise daily for 30 minutes, building up to 60 minutes over a four week period

  Start of study - 30 minutes building up to 60 minutes over a four week period

• Grasp Release Test (GRT)

  Test to be completed both with and without the device - exercise daily for 30 minutes, building up to 60 minutes over a four week period

  At the end of the clinical phase (week 10) - 30 minutes building up to 60 minutes over a four week period

• Grasp Release Test (GRT)

  Test to be completed both with and without the device - exercise daily for 30 minutes, building up to 60 minutes over a four week period

  At the end of the home phase for participants taking the device home (week 18) - 30 minutes building up to 60 minutes over a four week period

Secondary Outcomes (6)

• Measurement of palmar grip

  At the start of the study - 30 minutes

• Measurement of pinch grip

  At the start of the study - 30 minutes

• Measurement of palmar grip

  At the end of the clinical phase (week 10) - 30 minutes

• Measurement of pinch grip

  At the end of the clinical phase (week 10) - 30 minutes

• Measurement of palmar grip

  At the end of the home phase for participants taking the device home (week 18) - 30 minutes

Other Outcomes (3)

• Two Point Discrimination Test

  At the start of the study

• Two Point Discrimination Test

  At the end of the clinical phase (week 10)

• Two Point Discrimination Test

  At the end of the home phase for participants taking the device home (week 18)

Interventions

TetraGrip II system DEVICE

This main aim of this whole research project is to evaluate the performance of the TetraGrip II system in improving the upper limb functions in people with C4-C7 tetraplegia i.e. people who have damaged their spinal cord in the neck resulting in loss of function in all four limbs. The Tetragrip system uses a technique called Functional Electrical Stimulation (FES) in which small electrical impulses are used to activate paralysed muscles and hence provide movement. The stimulation is controlled by sensors which measure the movement of the other shoulder and enable the person to regain the use of their hand via stimulating electrodes placed on the skin over the relevant muscles. The feasibility of using this FES based system in restoring the upper arm functions will be evaluated by clinically trying the device on participants with C4-C7 tetraplegia.

Eligibility Criteria

• Age: 18 Years - 90 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Have a spinal cord injury that has resulted in tetraplegia affecting hand function.
• Minimal spasticity of wrist muscle.
• Able to do shoulder elevation.
• Upper limb passive range of motion should be within normal limit.
• Age group: 18 years and above.
• Able to understand and comply with assessment procedures.
• Able to give informed consent.
• Able to produce a muscle contraction using electrical stimulation in sufficient muscles produce a functional grip.

You may not qualify if:

• Using a cardiac pacemaker, defibrillator or other sensitive implanted device.
• Pregnant or planning to become pregnant over the course of the study.
• A history of poorly controlled epilepsy.
• If there is malignancy on the hand or arm.
• If younger than 18
• Severe contracture of wrist and finger joints.
• Painful shoulder.
• Suffering from significant autonomic dysreflexia in response to FES.

Sponsors & Collaborators

• Bournemouth University: lead
• Salisbury NHS Foundation Trust: collaborator

Study Sites (1)

Salisbury District Hospital

Salisbury, Wiltshire, SP2 8BJ, United Kingdom

Location

MeSH Terms

Conditions

Spinal Cord Injuries; Quadriplegia

Condition Hierarchy (Ancestors)

Spinal Cord Diseases; Central Nervous System Diseases; Nervous System Diseases; Trauma, Nervous System; Wounds and Injuries; Paralysis; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Officials

• Ian Swain, Professor

  Professor in Technology & Design

  STUDY DIRECTOR

• Paul Taylor, Professor

  Consultant Clinical Scientist - Salisbury District Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: NONE
• Purpose: BASIC SCIENCE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 23, 2021
• First Posted: July 16, 2021
• Study Start: October 26, 2021
• Primary Completion: August 31, 2022
• Study Completion: August 31, 2022
• Last Updated: November 14, 2022

Record last verified: 2022-11

Locations

GB (1)